DNA Capital

DNA Capital is an investment partnership specializing in multi-stage investments in the healthcare sector, ranging from early stage companies to private equity. Our mission is to invest in and provide strategic value to the best companies and founding teams in healthcare. Our team is multidisciplinary, deeply rooted in healthcare and passionate about finding and helping the best companies to thrive. DNA Capital was founded in 2013 and is part of one of the world's leading healthcare groups. We invest globally from our offices located in São Paulo, Brazil and San Francisco, California.

Carlos de Barros Jorge Neto

Partner

Lucas Cortez

Associate

Julia Prado

Analyst

Sergio Ricardo Santos

Partner

Suzie Kim Yoon

Associate

27 past transactions

Sanar

Debt Financing in 2022
Editora Sanar LTDA is a Brazilian publishing company based in Salvador that specializes in educational materials tailored for healthcare professionals. Established in 2014, the company focuses on creating customized online training and competitive preparatory courses for residency and civil service exams in medicine, nursing, and various other health fields. Sanar employs a team of over 100 professors from prestigious universities across Brazil, ensuring that their publications are academically rigorous and aligned with the goals of health students. The company emphasizes the importance of personalized teaching materials and maintains open communication channels with its customers to enhance product delivery and service quality. This commitment to customization and customer engagement is fundamental to Sanar's mission of supporting students in achieving their professional and academic objectives.

Inspirali

Private Equity Round in 2022
Operator of education institutions intended for medicine and health studies. The company offers face-to-face and digital learning for post-graduate studies, medical courses and improvement courses, thereby providing customers with access to learning and training in medical studies.

Reema Health

Seed Round in 2022
Reema Health is a technology startup focused on bridging the gaps between healthcare and social care. The company operates a healthcare platform that connects individuals with care and resources through tech-enabled community guides. By offering a personalized, community-based approach, Reema Health aims to help people identify specific steps to improve their behavioral health. This initiative facilitates easier access to medical care and supports individuals in enhancing their overall quality of life.

Nice Healthcare

Series A in 2022
Nice Healthcare LLC operates as a nurse practitioner-led primary care clinic based in Minneapolis, Minnesota, and was founded in 2017. The company specializes in providing "frictionless primary care," eliminating financial and access barriers for patients and clinicians. It delivers healthcare services through a combination of in-home and virtual visits, including primary care, 550+ prescriptions, in-home labs, in-home x-rays, virtual physical therapy, and chronic condition management. Nice Healthcare contracts directly with employers, offering unlimited access to its services at a transparent rate of $30 to $36 per employee per month, with no additional fees for dependents or visit charges. This model enables seamless access to healthcare for individuals, facilitated by licensed and certified nurse practitioners or physician assistants.

Cíngulo

Seed Round in 2022
Cíngulo offers emotional well-being through self-knowledge to improve self-esteem, mood, and attitude. It is personal evolution cycle for people. People can identify what to improve, enhance self-knowledge, and track the progress. Cíngulo is an application with exercises and techniques to strengthen the emotional health by exposing the contents and techniques gradually with mini-sessions, respecting the time necessary to process the emotional questions worked. Cíngulo was founded on 2017 and is headquartered in Porto Alegre, Brazil.

Anima Educação

Post in 2021
Anima Educação, founded in 2003 and based in São Paulo, Brazil, is an educational organization that operates primarily in the higher education sector. The company is involved in providing a range of educational services, including elementary and secondary education, college degrees, and professional specialization courses. Anima Educação also engages in various ancillary activities through its subsidiaries, which include organizing forums and seminars, publishing educational materials, and offering preparatory courses for the Brazilian Bar exam. The organization aims to enhance educational access and quality across different levels, reflecting its commitment to advancing education in Brazil.

Memed

Series C in 2021
Memed SA, founded in 2012 and based in Brazil, operates an online platform that provides e-prescription services and social collaboration tools for healthcare professionals. The platform enables doctors to create and manage digital prescriptions, facilitating effective treatment and improving patient adherence to prescribed medications. By connecting healthcare providers with key partners in the industry, Memed enhances the prescription process and supports communication among doctors, ultimately aiming to improve patient care and outcomes.

Cured

Series A in 2021
Cured, Inc. is a healthcare technology company that develops solutions for connecting health systems and healthcare organizations to patients and their families. The company’s platform solutions focus on network management, patient marketing and insights, and customer experience. Cured, Inc. was founded in 2018 and is headquartered in San Francisco, California with additional offices in Chicago and Denver.

Memed

Venture Round in 2021
Memed SA, founded in 2012 and based in Brazil, operates an online platform that provides e-prescription services and social collaboration tools for healthcare professionals. The platform enables doctors to create and manage digital prescriptions, facilitating effective treatment and improving patient adherence to prescribed medications. By connecting healthcare providers with key partners in the industry, Memed enhances the prescription process and supports communication among doctors, ultimately aiming to improve patient care and outcomes.

Beep Saúde

Series B in 2021
Operator of vaccination and home medical care platform intended to offer quality experiences in health services and simplify people's lives. The company specializes in providing home vaccination services via its vaccine marketplace application where users can choose their vaccine and schedule an appointment, provides an opportunity for new players to outpace incumbents, who are slow in adjusting their offerings to this new demand, enabling patients or healthcare-seeking users to get vaccinated and receive medical care economically in the comfort of their homes.

Spotlight Therapeutics

Series A in 2020
Spotlight Therapeutics is a developer of gene editing therapeutics intended to edit specific cell populations directly in the body. The company's therapeutics are used to create next-generation programmable nucleases that can selectively target and edit cells, enabling physicians to treat their patient in an enhanced way.

Vitable, LLC

Seed Round in 2020
Vitable, LLC is a healthcare provider based in Woodlyn, Pennsylvania, founded in 2019, that focuses on offering acute and preventive health coverage to under-insured Americans. The company aims to improve the traditional urgent care experience, which often involves long wait times and inadequate service. Vitable provides a range of services, including telemedicine, concierge urgent care, and various health screenings, all designed to prioritize patient convenience and satisfaction. By delivering quality care directly to patients' homes and maintaining transparency in billing, Vitable seeks to enhance the overall healthcare experience. Additionally, the company offers tailored solutions for businesses and specialized services for children, emphasizing its commitment to accessible and personalized healthcare.

Galileo

Series B in 2020
Galileo, Inc. is a technology company that specializes in developing healthcare mobile applications designed to facilitate medical care and expertise. Founded in 2014 and headquartered in Washington, D.C., the company provides an online communication platform that allows healthcare providers and patients to connect through synchronous and asynchronous telecommunications technologies. By leveraging these innovative solutions, Galileo aims to enhance access to comprehensive clinical care directly from mobile devices, improving the overall patient experience in healthcare delivery.

Sanar

Series B in 2020
Editora Sanar LTDA is a Brazilian publishing company based in Salvador that specializes in educational materials tailored for healthcare professionals. Established in 2014, the company focuses on creating customized online training and competitive preparatory courses for residency and civil service exams in medicine, nursing, and various other health fields. Sanar employs a team of over 100 professors from prestigious universities across Brazil, ensuring that their publications are academically rigorous and aligned with the goals of health students. The company emphasizes the importance of personalized teaching materials and maintains open communication channels with its customers to enhance product delivery and service quality. This commitment to customization and customer engagement is fundamental to Sanar's mission of supporting students in achieving their professional and academic objectives.

Beep Saúde

Series A in 2020
Operator of vaccination and home medical care platform intended to offer quality experiences in health services and simplify people's lives. The company specializes in providing home vaccination services via its vaccine marketplace application where users can choose their vaccine and schedule an appointment, provides an opportunity for new players to outpace incumbents, who are slow in adjusting their offerings to this new demand, enabling patients or healthcare-seeking users to get vaccinated and receive medical care economically in the comfort of their homes.

Memed

Series B in 2020
Memed SA, founded in 2012 and based in Brazil, operates an online platform that provides e-prescription services and social collaboration tools for healthcare professionals. The platform enables doctors to create and manage digital prescriptions, facilitating effective treatment and improving patient adherence to prescribed medications. By connecting healthcare providers with key partners in the industry, Memed enhances the prescription process and supports communication among doctors, ultimately aiming to improve patient care and outcomes.

The CareVoice

Series A in 2019
The CareVoice Limited is a Shanghai-based company that develops a mobile-based, data-driven software as a service (SaaS) solution aimed at enhancing the healthcare experience in China. Founded in 2013, the company provides a platform that features community-sourced ratings and recommendations for hospitals, doctors, and treatments. Patients can share their experiences through ratings and reviews based on their medical visits, fostering a collaborative environment for individuals undergoing similar treatments. The CareVoice aims to transform healthcare into a more consumer-centric experience, offering tools for insurers to create connected health ecosystems and improve patient engagement. The company also maintains an office in Hong Kong and has garnered support from prominent venture capital and healthcare investors.

blüüm

Seed Round in 2019
StartupCare is an insurtech startup founded by The CareVoice and its shareholders, offering tailored corporate health solutions to empower SMEs of Hong Kong. Built for startups by startup, for the love of Hong Kong.In partnership with Generali Hong Kong, StartupCare provides tailor-made employee health benefits solutions for SMEs with comprehensive health services and cost-effective medical plans for all ages and demographics, with access to a broad network of 2500+ medical providers through Generali’s partnership.

Feegow

Venture Round in 2019
Feegow Clinic is a clinical software that serves as a solution to all clinical and office management problems. The company exists since 2009 with the purpose of optimizing the routine of clinics, offices and hospitals throughout Brazil. Feegow Clinic meets the real needs of its audience, made up of different profiles in the health area.

Alto Pharmacy

Series C in 2019
Alto is a full-service pharmacy powered by a team of experts dedicated to making your doctor's orders their own. From delivering prescriptions to coordinating with insurance, digging for discounts, and answering, Alto works behind-the-scenes to remove any obstacles standing in the way of your care. The company started in 2015 and is headquartered in San Francisco, California.

uBiome

Series C in 2018
uBiome, Inc. is a microbial genomics company based in San Francisco, California, founded in 2012. The company specializes in developing sequencing-based clinical microbiome tests, which include SmartGut, a test that identifies pathogenic and commensal microorganisms linked to infections, and SmartJane, a women's health screening test that assesses multiple conditions such as HPV and STIs. Additionally, uBiome offers Explorer kits for citizen scientists and researchers, as well as SmartFlu, a clinical respiratory test. The firm aimed to empower patients and healthcare providers by providing insights into the human microbiome and its impact on health. However, uBiome faced financial difficulties, filing for Chapter 11 bankruptcy in September 2019, which was subsequently converted to Chapter 7 on October 11, 2019.

Cambridge Epigenetix

Series C in 2018
Cambridge Epigenetix Limited is a bioscience company based in Babraham, United Kingdom, focused on advancing clinical epigenetics. Founded in 2012, the company specializes in developing innovative tools for epigenetic analysis, particularly through its TrueMethyl technology, which allows for precise sequencing of hydroxymethylcytosine (5hmC) and methylcytosine (5mC). Its product offerings include TrueMethyl 6 and TrueMethyl 24 kits, designed for quantitative measurement and single-base resolution analysis of DNA methylation and hydroxymethylation. Cambridge Epigenetix aims to transform medical diagnostics by simplifying tests for colorectal cancer and other tumors to a single blood draw, leveraging the significant biomarker potential of 5hmC. The company emerged from the University of Cambridge, backed by notable investors including GV, Sequoia, and Syncona. Through its work, Cambridge Epigenetix seeks to enhance diagnostic and prognostic capabilities in medicine, aligning with its mission to improve human health.

Nuria

Series A in 2018
CM Tecnologia is a technology startup based in Belo Horizonte Brazil. The idea has become reality, and today we have more than 750 clients all over Brazil. We want to bring efficiency and cost reduction to hospitals and clinics by offering an online schedule integrated solution. No one wants to spend 30 minutes on the phone to schedule anything, especially when you're sick. Through the internet or mobile its easier, faster and convenient! Our mission is to bring peace to the provider, and convenience to the patient.

Omny, Inc.

Venture Round in 2018
Omny, Inc. is a technology company that specializes in developing an interoperable distributed ledger platform tailored for the pharmaceutical, biotechnology, and life sciences sectors. Founded in 2017 and based in Belmont, California, the company’s platform enhances the visibility and management of healthcare data by integrating with legacy systems and providing a secure, immutable chain of custody for real-time multiparty audits. This allows all network participants to maintain ownership of their data. Additionally, Omny offers a Dashboard feature that tracks data provenance in real time, delivering critical insights for business decision-making. The platform aims to create a connected ecosystem that facilitates collaboration among patients, providers, and life sciences organizations, thereby promoting scalable partnerships and fostering patient-centered, evidence-based care.

Arterys

Series B in 2017
Arterys Inc. is a technology company specializing in medical imaging analytics, aiming to enhance patient care through innovative solutions. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a cloud-based, AI-powered platform that enables radiologists to visualize and quantify blood flow in the body. Its product lineup includes Cardio AI for cardiac imaging, Lung AI for lung analysis, Liver AI for liver diagnostics, and Chest/MSK AI for detecting various thoracic and musculoskeletal conditions. The platform is fully web-based and FDA-cleared, providing clinicians with tools for automatic and interactive reporting. Additionally, the Arterys PHI Service allows physicians to access patient data remotely, further supporting efficient medical practices.

Beep Saúde

Seed Round in 2017
Operator of vaccination and home medical care platform intended to offer quality experiences in health services and simplify people's lives. The company specializes in providing home vaccination services via its vaccine marketplace application where users can choose their vaccine and schedule an appointment, provides an opportunity for new players to outpace incumbents, who are slow in adjusting their offerings to this new demand, enabling patients or healthcare-seeking users to get vaccinated and receive medical care economically in the comfort of their homes.

Clover Health

Series D in 2017
Clover Health is a health insurance company that specializes in providing Medicare Advantage plans for senior citizens. Founded in 2014 and headquartered in San Francisco, California, the company also has offices in several states, including New Jersey, Arizona, Georgia, Pennsylvania, South Carolina, Tennessee, and Texas. Clover Health operates a Preferred Provider Organization (PPO) platform that aims to enhance the quality of life for its members through patient-centered analytics and dedicated care management. By utilizing advanced analytics and custom software, Clover Health directs its clinical staff to proactively address gaps in care, focusing on preventive measures and chronic disease management. Its approach not only aims to improve health outcomes but also seeks to reduce unnecessary healthcare spending. The company primarily generates revenue through its insurance segment, which offers both PPO and Health Maintenance Organization (HMO) plans.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.